
---
title: '每季一针_美药厂开始新冠与流感混合疫苗临床试验'
categories: 
 - 新媒体
 - 快媒体
 - 首页更新
headimg: 'https://www.kuai.media/news/2021/09/09/static/image/kuai/external-link.gif'
author: 快媒体
comments: false
date: 2021-09-09 00:26:13
thumbnail: 'https://www.kuai.media/news/2021/09/09/static/image/kuai/external-link.gif'
---

<div>   
<a href="https://www.kuai.media/go.php?aid=269132" target="_blank" role="link" data-focusable="true" class="sum" rel=" noopener noreferrer">

<strong>摘要</strong>: Vaccine-maker Novavax kicks off trial for combined Covid-19/flu jab - https://t.co/vRNDpIpI8s -American vaccine-maker Novavax has started its early stage trial of a vaccine which combines an as-yet-unapproved Covid-19 shot with the company’s NanoFlu influenza jab. ... pic.twitter.com/UkKjeKwvAJmdash; kashco.co.uk (@Kashco_co_uk) September 8, 2021美国生技药厂诺瓦瓦克斯（Novavax）今天宣布，旗下由流感疫苗和COVID-19疫苗结合而成的新疫苗NanoFlu/NVX-CoV2373，已展开初期临床试验。路透社报导，诺瓦瓦克斯先前指出，NanoFlu/NVX-CoV2373的临床前研究显示，这支疫苗不仅对于A型和B型流感能引起很强的免疫反 ... <span class="more"><img width="35" src="https://www.kuai.media/news/2021/09/09/static/image/kuai/external-link.gif" referrerpolicy="no-referrer">点击阅读全文 @wenxuecity.com</span>
</a>


  
</div>
            